Blood banks worldwide face a persistent problem: donated blood has a short shelf life, matching donors to patients is never guaranteed, and supply chains can fail exactly when demand spikes. This film traces the history of transfusion medicine, including the 1980s scandal in which contaminated blood products infected thousands of patients with HIV and Hepatitis C, to explain why the field has spent decades chasing a synthetic substitute. Scientists and clinicians walk through the biology of why blood is so hard to replicate, from oxygen-carrying capacity to immune compatibility, and the film surveys the various approaches researchers have tried, from hemoglobin-based carriers to lab-grown blood cells. Archival material and expert interviews lay out both the promise of a shelf-stable, universally compatible alternative and the setbacks that have kept synthetic blood from reaching hospitals. The result is a grounded look at a medical problem most viewers never think about until a transfusion is the only thing keeping someone alive.